Lab Information

Dr. Alexandra De Pokomandy

Centre for Outcomes Research and Evaluation
Department of Family Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 20%
 Epidemiology: 80%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Human papillomavirus • HPV • HIV • Primary Care

Research Interests

My research focuses on HIV health care, mainly co-morbidities associated with HIV, women's health and integrated HIV primary care. I am particularly interested on the impact of human papillomavirus (HPV) in people living with HIV, including HPV infection, secondary intraepithelial lesions and cancers, in both men having sex with men and women, particularly concerning anal cancer prevention. Another aspect of my research looks at the broader general, reproductive and sexual health and wellbeing of women living with HIV, including assessing women's needs in comparison to current accessibility to services in Canada.

Team Members

Name Position
Ayosanmi, Oluwasola PhD Student
Skerritt, Lashanda PhD Student

Latest Publications

  1. Grewal, R., Deeks, S. L., Hart, T. A., Cox, J., De Pokomandy, A., Grennan, T., Lambert, G., Moore, D., Brisson, M., Coutlée, F., Gaspar, M., George, C., Grace, D., Jollimore, J., Lachowsky, N. J., Nisenbaum, R., Ogilvie, G., Sauvageau, C., Tan, D. H. S., Yeung, A. & Burchell, A. N. (2021). Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019. Vaccine, vol. 39, p. 3756-3766.
  2. Loutfy, M., Tharao, W., Kazemi, M., Logie, C. H., Underhill, A., O'Brien, N., Pick, N., Kestler, M., H Yudin, M., Rana, J., MacGillivray, J., Kennedy, V. L., Jaworsky, D., Carvalhal, A., Conway, T., Webster, K., Lee, M., Islam, S., Nicholson, V., Ndung'u, M., Proulx-Boucher, K., Carter, A., Gormley, R., Narasimhan, M., Welbourn, A., de Pokomandy, A., Kaida, A. & CHIWOS Research Team (2021). Development of the Canadian Women-Centred HIV Care Model Using the Knowledge-to-Action Framework. Journal of the International Association of Providers of AIDS Care, vol. 20, p. 2325958221995612.
  3. Fehr, D., Lebouché, B., Ruppenthal, L., Brownc, M., Obasc, N., Bourbonnière, E., Girouard, J., Massicotte, A., Jenabian, M.-A., Almomen, A.-A., Frenette, C., de Pokomandy, A., Cox, J., Giannakis, A., Cheng, M., Kronfli, N., Tsoukas, C., Zahedi, N., Szabo, J., Dehghani, K., Brouillette, M.-J., Falutz, J., Turner, H., Hamel, A., Duchesneau, C., Lanthier-Brun, J., Klein, M., Routy, J.-P. & Costiniuk, C. T. (2021). Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic. AIDS care, p. 1-7.
  4. Chu, D., Schuster, T., Lessard, D., Mate, K., Engler, K., Ma, Y., Abulkhir, A., Arora, A., Long, S., de Pokomandy, A., Lacombe, K., Rougier, H., Cox, J., Kronfli, N., Hijal, T., Kildea, J., Routy, J.-P., Asselah, J. & Lebouché, B. (2021). Acceptability of a Patient Portal (Opal) in HIV Clinical Care: A Feasibility Study. Journal of personalized medicine, vol. 11.
  5. Laurie, C., El-Zein, M., Coutlée, F., de Pokomandy, A. & Franco, E. L. (2021). Carrageenan as a preventive agent against human papillomavirus infection: a narrative review. Sexually transmitted diseases, vol. 48, p. 458-465.
  6. Sangaré, M. N., Baril, J.-G., de Pokomandy, A., Laprise, C., Deshaies, C., Klein, M., Thomas, R., Tremblay, C., Roger, M., Pexos, C., Greenwald, Z., Machouf, N., Durand, M., Hardy, I., Dakouo, M., Laporte, L. & Trottier, H. (2020). Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV. Medicine, vol. 99, p. e23335.
  7. Sangaré, M. N., Baril, J.-G., de Pokomandy, A., Ferreira Guerra, S., Carabali, M., Laprise, C., Thomas, R., Klein, M., Tremblay, C., Roger, M., Pexos, C., Greenwald, Z. R., Machouf, N., Durand, M., Hardy, I., Dakouo, M., Trevisan, A., Laporte, L., Schnitzer, M. E. & Trottier, H. (2020). Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data. Open forum infectious diseases, vol. 7, p. ofaa404.
  8. Clifford, G. M., Georges, D., Shiels, M. S., Engels, E. A., Albuquerque, A., Poynten, I. M., de Pokomandy, A., Easson, A. M. & Stier, E. A. (2021). A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. International journal of cancer, vol. 148, p. 38-47.
  9. O'Brien, N., Godard-Sebillotte, C., Skerritt, L., Dayle, J., Carter, A., Law, S., Cox, J., Andersson, N., Kaida, A., Loutfy, M., de Pokomandy, A. & CHIWOS Research Team (2020). Assessing Gaps in Comprehensive HIV Care Across Settings of Care for Women Living with HIV in Canada. Journal of women's health (2002), vol. 29, p. 1475-1485.
  10. O'Brien, N., Law, S., Proulx-Boucher, K., Ménard, B., Skerritt, L., Boucoiran, I., Cox, J., Andersson, N. & de Pokomandy, A. (2020). Codesigning care improvements for women living with HIV: a patient-oriented deliberative dialogue workshop in Montréal, Quebec. CMAJ open, vol. 8, p. E264-E272.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile


Latest News


Research groups